Showing results (261-270 of 274) with videos related to

Sort By:
Pageof 28
Frontiers in Pharmacology|December 25, 2025
Validation of diagnostic screening test for pharmacogenomic targets for thiopurine drugs in indian pediatric acute lymphoblastic leukemia patientsGratial Theres Joseph, Sandeep Kumar Swain, Tejas Somwanshi, et al.
Indian Journal of Pharmacology|February 1, 2023
Virtual screening and molecular dynamics simulation study of approved drugs as a binder to the linoleic acid binding site on spike protein of SARS-CoV-2 and double mutant (E484Q and L452R)Manisha Prajapat, Phulen Sarma, Nishant Shekhar, et al.
Acta Biomaterialia|May 18, 2025
Deciphering pericyte-induced temozolomide resistance in glioblastoma with a 3D microphysiological system mimicking the biomechanical properties of brain tissueSurjendu Maity, Christopher Jewell, Can Yilgor, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
Predicting targeted- and immunotherapeutic response outcomes in melanoma with single-cell Raman spectroscopy and AIKai Chang, Mamatha Serasanambati, Baba Ogunlade, et al.
Bioinformatics and Biology Insights|August 3, 2023
Structural-Based Virtual Screening of FDA-Approved Drugs Repository for NSP16 Inhibitors, Essential for SARS-COV-2 Invasion Into Host Cells: Elucidation From MM/PBSA CalculationSubodh Kumar, Harvinder Singh, Manisha Prajapat, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 17, 2022
Organ-On-A-Chip Models of the Blood-Brain Barrier: Recent Advances and Future ProspectsSatoru Kawakita, Kalpana Mandal, Lei Mou, et al.
Hypertension (Dallas, Tex. : 1979)|June 22, 2016
Catestatin Gly364Ser Variant Alters Systemic Blood Pressure and the Risk for Hypertension in Human Populations via Endothelial Nitric Oxide PathwayMalapaka Kiranmayi, Venkat R Chirasani, Prasanna K R Allu, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 13, 2024
Recent Developments in Glioblastoma-On-A-Chip for Advanced Drug Screening ApplicationsSurjendu Maity, Tamanna Bhuyan, Christopher Jewell, et al.
Diabetes|December 4, 2021
Functional Gly297Ser Variant of the Physiological Dysglycemic Peptide Pancreastatin Is a Novel Risk Factor for Cardiometabolic DisordersPrasanna K R Allu, Malapaka Kiranmayi, Sromona D Mukherjee, et al.
The Journal of Urology|June 18, 2011
Positive surgical margins after robotic assisted radical prostatectomy: a multi-institutional studyVipul R Patel, Rafael F Coelho, Bernardo Rocco, et al.
Pageof 28